New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.
Alexia AlexandrakiElisavet PapageorgiouMarina ZachariaKalliopi KeramidaAntroula PapakonstantinouCarlo M CipollaDorothea TsekouraKaterina K NakaKetti MazzoccoDavide MauriManolis TsiknakisGeorgios C ManikisKostas MariasYiola MarcouEleni KakouriIfigenia KonstantinouMaria DanielMyria GalaziEffrosyni KampouroglouDomen RibnikarCameron BrownGeorgia KaranasiouAthos AntoniadesDimitrios Ioannis FotiadisGerasimos FilippatosAnastasia ConstantinidouPublished in: Cancers (2023)
We highlighted the new insights associated with the use of currently available biomarkers as a standard of care for the management of CTRCD and identified potentially novel clinical biomarkers that could be further investigated as promising predictors of CTRCD.